- -

Mesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/ drugs in colon

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Mesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/ drugs in colon

Show full item record

Ferri, D.; Gaviña, P.; Parra Álvarez, M.; Costero, AM.; El Haskouri, J.; Amorós Del Toro, P.; Merino Sanjuán, V.... (2018). Mesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/ drugs in colon. Royal Society Open Science. 5(8). https://doi.org/10.1098/rsos.180873

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/143317

Files in this item

Thumbnail
Name: Ferri;Gaviña;Parra ...
Size: 1.161Mb
Format: PDF
Description: Versión editorial
Open/Preview

Item Metadata

Title: Mesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/ drugs in colon
Author: Ferri, Daniel Gaviña, Pablo Parra Álvarez, Margarita Costero, Ana M. El Haskouri, Jamal Amorós del Toro, Pedro Merino Sanjuán, Virginia Teruel, Adrián H Sancenón Galarza, Félix Martínez-Máñez, Ramón
UPV Unit: Universitat Politècnica de València. Instituto de Reconocimiento Molecular y Desarrollo Tecnológico - Institut de Reconeixement Molecular i Desenvolupament Tecnològic
Universitat Politècnica de València. Departamento de Química - Departament de Química
Issued date:
Abstract:
[EN] Mesoporous silica microparticles were prepared, loaded with the dye safranin O (M-Saf) or with the drug budesonide (M-Bud) and capped by the grafting of a bulky azo derivative. Cargo release from M-Saf at different ...[+]
Subjects: Mesoporous silica microparticles , Gated materials , Controlled drug release , Colon targeting , Inflammatory bowel disease , Budesonide
Copyrigths: Reconocimiento (by)
Source:
Royal Society Open Science. (eissn: 2054-5703 )
DOI: 10.1098/rsos.180873
Publisher:
The Royal Society
Publisher version: https://doi.org/10.1098/rsos.180873
Project ID:
MICINN/MAT2015-64139-C4-1-R
GV/AICO/2017/093
info:eu-repo/grantAgreement/MINECO//MAT2015-64139-C4-4-R/ES/QUIMIOSENSORES CROMOGENICOS Y FLUOROGENICOS PARA LA DETECCION DE NEUROTRASMISORES/
info:eu-repo/grantAgreement/MINECO//MAT2015-64139-C4-2-R/ES/SOLIDOS MESOPOROSOS Y PARTICULADOS PARA EL DISEÑO DE MATERIALES TERANOSTICOS/
GENERALITAT VALENCIANA/PROMETEOII/2014/047
Thanks:
We thank the Spanish Government (projects MAT2015-64139-C4-4-R, MAT2015-64139-C4-2-R and MAT2015-64139-C4-1-R) and Generalitat Valenciana (project PROMETEOII/2014/047 and project AICO/2017/093) for financial support.
Type: Artículo

References

Xu, X.-M., & Zhang, H.-J. (2016). miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation. World Journal of Gastroenterology, 22(7), 2206-2218. doi:10.3748/wjg.v22.i7.2206

DeFilippis, E. M., Longman, R., Harbus, M., Dannenberg, K., & Scherl, E. J. (2016). Crohn’s Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies. Current Gastroenterology Reports, 18(3). doi:10.1007/s11894-016-0487-z

Fakhoury, M., Al-Salami, H., Negrulj, R., & Mooranian, A. (2014). Inflammatory bowel disease: clinical aspects and treatments. Journal of Inflammation Research, 113. doi:10.2147/jir.s65979 [+]
Xu, X.-M., & Zhang, H.-J. (2016). miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation. World Journal of Gastroenterology, 22(7), 2206-2218. doi:10.3748/wjg.v22.i7.2206

DeFilippis, E. M., Longman, R., Harbus, M., Dannenberg, K., & Scherl, E. J. (2016). Crohn’s Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies. Current Gastroenterology Reports, 18(3). doi:10.1007/s11894-016-0487-z

Fakhoury, M., Al-Salami, H., Negrulj, R., & Mooranian, A. (2014). Inflammatory bowel disease: clinical aspects and treatments. Journal of Inflammation Research, 113. doi:10.2147/jir.s65979

Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., … Driscoll, R. (2011). Guidelines for the management of inflammatory bowel disease in adults. Gut, 60(5), 571-607. doi:10.1136/gut.2010.224154

Zeng, J., Lv, L., & Mei, Z.-C. (2017). Budesonide foam for mild to moderate distal ulcerative colitis: A systematic review and meta-analysis. Journal of Gastroenterology and Hepatology, 32(3), 558-566. doi:10.1111/jgh.13604

Gareb, B., Eissens, A. C., Kosterink, J. G. W., & Frijlink, H. W. (2016). Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease. European Journal of Pharmaceutics and Biopharmaceutics, 103, 32-42. doi:10.1016/j.ejpb.2016.03.018

Marín-Jiménez, I., & Peña, A. S. (2006). Budesonide for ulcerative colitis. Revista Española de Enfermedades Digestivas, 98(5). doi:10.4321/s1130-01082006000500007

Abdalla, M. I., & Herfarth, H. (2016). Budesonide for the treatment of ulcerative colitis. Expert Opinion on Pharmacotherapy, 17(11), 1549-1559. doi:10.1080/14656566.2016.1183648

Horcajada, P., Chalati, T., Serre, C., Gillet, B., Sebrie, C., Baati, T., … Gref, R. (2009). Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nature Materials, 9(2), 172-178. doi:10.1038/nmat2608

Florek, J., Caillard, R., & Kleitz, F. (2017). Evaluation of mesoporous silica nanoparticles for oral drug delivery – current status and perspective of MSNs drug carriers. Nanoscale, 9(40), 15252-15277. doi:10.1039/c7nr05762h

Du, X., Li, X., Xiong, L., Zhang, X., Kleitz, F., & Qiao, S. Z. (2016). Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery. Biomaterials, 91, 90-127. doi:10.1016/j.biomaterials.2016.03.019

Argyo, C., Weiss, V., Bräuchle, C., & Bein, T. (2013). Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery. Chemistry of Materials, 26(1), 435-451. doi:10.1021/cm402592t

Noureddine, A., & Brinker, C. J. (2018). Pendant/bridged/mesoporous silsesquioxane nanoparticles: Versatile and biocompatible platforms for smart delivery of therapeutics. Chemical Engineering Journal, 340, 125-147. doi:10.1016/j.cej.2018.01.086

Wight, A. P., & Davis, M. E. (2002). Design and Preparation of Organic−Inorganic Hybrid Catalysts. Chemical Reviews, 102(10), 3589-3614. doi:10.1021/cr010334m

Stein, A. (2003). Advances in Microporous and Mesoporous Solids—Highlights of Recent Progress. Advanced Materials, 15(10), 763-775. doi:10.1002/adma.200300007

Alberti, S., Soler-Illia, G. J. A. A., & Azzaroni, O. (2015). Gated supramolecular chemistry in hybrid mesoporous silica nanoarchitectures: controlled delivery and molecular transport in response to chemical, physical and biological stimuli. Chemical Communications, 51(28), 6050-6075. doi:10.1039/c4cc10414e

Coll, C., Bernardos, A., Martínez-Máñez, R., & Sancenón, F. (2012). Gated Silica Mesoporous Supports for Controlled Release and Signaling Applications. Accounts of Chemical Research, 46(2), 339-349. doi:10.1021/ar3001469

Croissant, J., Maynadier, M., Gallud, A., Peindy N’Dongo, H., Nyalosaso, J. L., Derrien, G., … Zink, J. I. (2013). Two-Photon-Triggered Drug Delivery in Cancer Cells Using Nanoimpellers. Angewandte Chemie, 125(51), 14058-14062. doi:10.1002/ange.201308647

Croissant, J., Chaix, A., Mongin, O., Wang, M., Clément, S., Raehm, L., … Zink, J. I. (2014). Two-Photon-Triggered Drug Delivery via Fluorescent Nanovalves. Small, 10(9), 1752-1755. doi:10.1002/smll.201400042

Ambrogio, M. W., Thomas, C. R., Zhao, Y.-L., Zink, J. I., & Stoddart, J. F. (2011). Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine. Accounts of Chemical Research, 44(10), 903-913. doi:10.1021/ar200018x

Bansal, A., & Zhang, Y. (2014). Photocontrolled Nanoparticle Delivery Systems for Biomedical Applications. Accounts of Chemical Research, 47(10), 3052-3060. doi:10.1021/ar500217w

Doane, T. L., & Burda, C. (2012). The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chemical Society Reviews, 41(7), 2885. doi:10.1039/c2cs15260f

Amidon, S., Brown, J. E., & Dave, V. S. (2015). Colon-Targeted Oral Drug Delivery Systems: Design Trends and Approaches. AAPS PharmSciTech, 16(4), 731-741. doi:10.1208/s12249-015-0350-9

Hua, S., Marks, E., Schneider, J. J., & Keely, S. (2015). Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue. Nanomedicine: Nanotechnology, Biology and Medicine, 11(5), 1117-1132. doi:10.1016/j.nano.2015.02.018

Aznar, E., Oroval, M., Pascual, L., Murguía, J. R., Martínez-Máñez, R., & Sancenón, F. (2016). Gated Materials for On-Command Release of Guest Molecules. Chemical Reviews, 116(2), 561-718. doi:10.1021/acs.chemrev.5b00456

Llopis-Lorente, A., Lozano-Torres, B., Bernardos, A., Martínez-Máñez, R., & Sancenón, F. (2017). Mesoporous silica materials for controlled delivery based on enzymes. Journal of Materials Chemistry B, 5(17), 3069-3083. doi:10.1039/c7tb00348j

Popat, A., Jambhrunkar, S., Zhang, J., Yang, J., Zhang, H., Meka, A., & Yu, C. (2014). Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery. Chem. Commun., 50(42), 5547-5550. doi:10.1039/c4cc00620h

Li, X., Tang, T., Zhou, Y., Zhang, Y., & Sun, Y. (2014). Applicability of enzyme-responsive mesoporous silica supports capped with bridged silsesquioxane for colon-specific drug delivery. Microporous and Mesoporous Materials, 184, 83-89. doi:10.1016/j.micromeso.2013.09.024

Teruel, A., Coll, C., Costero, A., Ferri, D., Parra, M., Gaviña, P., … Sancenón, F. (2018). Functional Magnetic Mesoporous Silica Microparticles Capped with an Azo-Derivative: A Promising Colon Drug Delivery Device. Molecules, 23(2), 375. doi:10.3390/molecules23020375

Bernardos, A., Aznar, E., Marcos, M. D., Martínez-Máñez, R., Sancenón, F., Soto, J., … Amorós, P. (2009). Enzyme-Responsive Controlled Release Using Mesoporous Silica Supports Capped with Lactose. Angewandte Chemie International Edition, 48(32), 5884-5887. doi:10.1002/anie.200900880

Llopis-Lorente, A., Díez, P., Sánchez, A., Marcos, M. D., Sancenón, F., Martínez-Ruiz, P., … Martínez-Máñez, R. (2017). Interactive models of communication at the nanoscale using nanoparticles that talk to one another. Nature Communications, 8(1). doi:10.1038/ncomms15511

Viscido, A., Capannolo, A., Latella, G., Caprilli, R., & Frieri, G. (2014). Nanotechnology in the treatment of inflammatory bowel diseases. Journal of Crohn’s and Colitis, 8(9), 903-918. doi:10.1016/j.crohns.2014.02.024

Kickelbick, G. (2004). Hybrid Inorganic–Organic Mesoporous Materials. Angewandte Chemie International Edition, 43(24), 3102-3104. doi:10.1002/anie.200301751

Perry, M. J., Mendes, E., Simplício, A. L., Coelho, A., Soares, R. V., Iley, J., … Francisco, A. P. (2009). Dopamine- and tyramine-based derivatives of triazenes: Activation by tyrosinase and implications for prodrug design. European Journal of Medicinal Chemistry, 44(8), 3228-3234. doi:10.1016/j.ejmech.2009.03.025

Cabrera, S., El Haskouri, J., Guillem, C., Latorre, J., Beltrán-Porter, A., Beltrán-Porter, D., … Amorós *, P. (2000). Generalised syntheses of ordered mesoporous oxides: the atrane route. Solid State Sciences, 2(4), 405-420. doi:10.1016/s1293-2558(00)00152-7

[-]

recommendations

 

This item appears in the following Collection(s)

Show full item record